Identification of Hydroxyanthraquinones as Novel Inhibitors of Hepatitis C Virus NS3 Helicase
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification of Hydroxyanthraquinones as Novel Inhibitors of Hepatitis C Virus NS3 Helicase
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 16, Issue 8, Pages 18439-18453
Publisher
MDPI AG
Online
2015-08-07
DOI
10.3390/ijms160818439
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Retreatment with peginterferon and ribavirin in chronic hepatitis C
- (2015) Yong Min Jo WORLD JOURNAL OF GASTROENTEROLOGY
- Necrosis targeted combinational theragnostic approach using radioiodinated Sennidin A in rodent tumor models
- (2015) Yun Ji et al. Oncotarget
- Identification and Biochemical Characterization of Halisulfate 3 and Suvanine as Novel Inhibitors of Hepatitis C Virus NS3 Helicase from a Marine Sponge
- (2014) Atsushi Furuta et al. Marine Drugs
- Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection
- (2014) Nezam Afdhal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection
- (2014) Nezam Afdhal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis
- (2014) Kris V. Kowdley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Aurintricarboxylic Acid Modulates the Affinity of Hepatitis C Virus NS3 Helicase for Both Nucleic Acid and ATP
- (2013) William R. Shadrick et al. BIOCHEMISTRY
- Cholesterol sulfate as a potential inhibitor of hepatitis C virus NS3 helicase
- (2013) Atsushi Furuta et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trial
- (2013) Eric Lawitz et al. LANCET
- The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection
- (2013) Ralf Bartenschlager et al. NATURE REVIEWS MICROBIOLOGY
- The natural compound Alizarin as an osteotropic drug for the treatment of bone tumors
- (2012) Caterina Fotia et al. JOURNAL OF ORTHOPAEDIC RESEARCH
- An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases
- (2011) Marc G. Ghany et al. HEPATOLOGY
- Boceprevir for Untreated Chronic HCV Genotype 1 Infection
- (2011) Fred Poordad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Real-time monitoring of RNA helicase activity using fluorescence resonance energy transfer in vitro
- (2010) Hidenori Tani et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Hypericins as Potential Leads for New Therapeutics
- (2010) Anastasia Karioti et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Assembly of infectious hepatitis C virus particles
- (2010) Ralf Bartenschlager et al. TRENDS IN MICROBIOLOGY
- High-throughput screening assay of hepatitis C virus helicase inhibitors using fluorescence-quenching phenomenon
- (2009) Hidenori Tani et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Amidinoanthracyclines – a new group of potential anti-hepatitis C virus compounds
- (2009) Mariusz Krawczyk et al. BIOLOGICAL CHEMISTRY
- Helicase inhibitors as specifically targeted antiviral therapy for hepatitis C
- (2009) Craig A Belon et al. Future Virology
- Telaprevir and Peginterferon with or without Ribavirin for Chronic HCV Infection
- (2009) Christophe Hézode et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diagnosis, management, and treatment of hepatitis C: An update
- (2008) Marc G. Ghany et al. HEPATOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started